Strados Respiratory Care Platform

Enabling clinicians to monitor respiratory health from hospital to home.

  • FDA 510(k) cleared and CE marked
  • Patient and clinician friendly
  • Clinically validated 
asthma monitoring device - RESP Biosensor

Technology Overview

Cardiopulmonary diseases such as COPD, asthma and heart failure are among the most difficult to manage, with more than five million patients discharged from the hospital each year and readmissions for COPD often exceeding 20% within 30 days. The Strados Respiratory Care Platform, which includes our FDA-cleared RESP Biosensor, allows clinicians to continuously monitor lung sounds including cough and wheeze to gain greater insight into respiratory status and make earlier interventions that can save lives and resources.

Albert Rizzo, MD | Chief Medical Officer at American Lung Society

Data Collection Capabilities

Monitor early indicators of worsening respiratory diseases such as COPD & Asthma



Allows for identification of cough frequency, severity, and type


Wheeze, Rhonchi & Crackles

Allows for identification of frequency and inspiratory/expiratory events


Respiratory Dynamics*

Measures shortness of breath via respiratory rate as well as activity level

*Not cleared by FDA and for investigational use only.

How our wearable device works

The Strados Respiratory Care Platform is clinician and patient-friendly

asthma wearable monitoring device


Device is attached to patient’s chest with adhesive either by clinician or patient 



Lung sound data is transferred via bluetooth to patient mobile app after recording is started



Mobile device transfers data to the cloud and clinician portal, allowing clinical teams to review data and diagnose

Why this… why now?


  • Studies show patients don’t comply regularly with eDiaries
  • Most patients report have difficulty with self-reporting of symptoms and identifying onset of acute events
  • Auscultation with a stethoscope is limited to in-person visits, prone to interobserver variability and not archivable
  • Standard of care such as spirometry and pulse oximetry suffer from user error and lagging indication of decompensation
  • Increases in cough and wheeze as well as shortness of breath are early warning signs of a COPD or asthma flareup
respiratory monitoring devices patient wearing resp

Patient-Centered Design

The RESP Biosensor is small, unobtrusive and hands-free—patients even forget they’re wearing it. ‘Set it and forget it’, our wearable device records lung sounds continuously whether patients are sleeping, working out or enjoying time with family. That translates into more patient compliance and more complete data for clinicians and care teams.

Strados Clinician Portal 

Supported by machine learning* with archivable patient data

Our machine learning algorithms* including CoughCheck and WheezeCheck identify and track events with high clinical accuracy.

*Machine learning algorithms not cleared by FDA

Lung recordings are depicted visually as spectrograms. Recordings are also available for playback.

Technologies such as machine learning have the potential to break the cycle of COPD-related readmissions and provide respiratory patients a better quality of life.

Albert Rizzo, MD

Chief Medical Officer, American Lung Association

After the pandemic especially, we know that many patients are not always able to come into the hospital. Having the ability to see and monitor patients remotely is key.

Sadia Benzaquen, MD

Chair of Pulmonary Critical Care, Einstein Health Network

Let’s Talk.

We’d love to know how we can help you and your patients.

Join us at the American Cough Conference in Reston, VA - June 9-10!
This is default text for notification bar